Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
1
Pubs (1 yr)
P/LP submissions
P/LP missense
0.58
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.58LOEUF
pLI 0.002
Z-score 3.31
OE 0.34 (0.210.58)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-1.92Z-score
OE missense 1.23 (1.161.31)
672 obs / 545.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.34 (0.210.58)
00.351.4
Missense OE?1.23 (1.161.31)
00.61.4
Synonymous OE?1.30
01.21.6
LoF obs/exp: 10 / 29.4Missense obs/exp: 672 / 545.7Syn Z: -3.38

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ZNF518B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →